Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 16Radiotherapy 11Lomustine 8Carmustine 6Vincristine 5Procarbazine 5Etoposide 3Corticotropin-Releasing Hormone 3Carboplatin 3vorasidenib 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Isotretinoin 2Everolimus 2Dihematoporphyrin Ether 2Cisplatin 2Chemotherapy, Adjuvant 2etoposide phosphate 1carmustine, poliferprosan 20 drug combination 1Valproic Acid 1Tranexamic Acid 1Trabedersen 1Thioguanine 1Surgical Procedures, Operative 1Semustine 1Radiotherapy, Conformal 1Radiosurgery 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Astrocytoma × Methylphenidate × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡